To this end, we performed immunohistochemistry for IL9R on the lung tissue arrays of our cohort of NSCLC patients and found an upregulation of IL-9R in the tumoral region as compared to the control region and healthy controls (Figure 3A). Here, IL9R is linked to non-small cell lung carcinoma.